Miliary tuberculosis in a patient with rheumatoid arthritis following treatment with anti-TNF-α
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2008, Vol 25, Issue 2
Abstract
Anti-TNF-α agents have been used for the treatment of several autoimmune diseases, including rheumatoid arthritis. Recently observations indicate that treatment with anti-TNF-α agents is associated with increased risk of infectious diseases and especially tuberculosis. A case of a 78-year-old female with rheumatoid arthritis is described who developed miliary tuberculosis after treatment with infliximab. A brief review of the literature is presented.
Authors and Affiliations
A. Papaioannou, K. Kostikas, E. Gerogianni, M. IOANNOU
Keywords
Related Articles
- EP ID EP107582
- DOI -
- Views 72
- Downloads 0
175 YEARS OF THE ATHENS MEDICAL SOCIETY
No abstract available
Paraneoplastic hypokalemia
No abstract available
When and what is the ideal first-line therapy for low-grade B-cell non-Hodgkin lymphomas?
Low-grade B-cell non-Hodgkin lymphomas (B-NHL) are malignant diseases of the lymphatic tissue, the diagnosis and treatment of which may involve not only the lymphoma specialist but also physicians of many other specialti...
The role of laparoscopy in abdominal trauma
Despite the medical and technological development in recent decades, trauma continues to be a major cause of mortality and morbidity, increasing incidence. Early and accurate diagnosis allows prompt therapy, resulting in...
The effect of fenofibrate on plasma and HDL levels of PAF-acetylhydrolase: <br /> A new modulating action of the fibrates?
OBJECTIVE Human plasma platelet activating factor acetylhydrolase (PAF-AH) is an enzyme associated mainly with the apolipoprotein B-containing lipoproteins. A small proportion of circulating enzyme activity is also assoc...